Finder G6PD
FDA 510(k) K201049 · Baebies, Inc.
510(k) numberK201049
Submission
- Device name
- Finder G6PD
- Applicant
- Baebies, Inc.
Morrisville, NC, US - Received
- April 21, 2020
- Decision date
- September 14, 2022
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- JBF – Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 864.7360
- Specialty
- Hematology
Other 510(k)s with product code JBF
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K161364 | BinaxNOW G6PD TestJBF · Special | Alere Scarborough, Inc. | 06/17/2016SE |
| K080003 | Binaxnow G6PD TestJBF · Traditional | Binax, Inc. | 10/23/2008SE |
| K024006 | G6PDH, GLUCOSE-6-PHOSHATE DehydrogenaseJBF · Traditional | Pointe Scientific, Inc., | 03/31/2003SE |
| K933934 | GLUCOSE-6-PHOSPHATE Dehydrogenase Deficiency Screening Test Kit No. 202-AJBF · Traditional | Sigma Diagnostics, Inc. | 06/29/1995SE |
More from Sigma Diagnostics, Inc.
Questions and answers
When was Finder G6PD cleared by the FDA?
Finder G6PD (K201049) received a 510(k) decision of Substantially Equivalent on September 14, 2022, 876 days after the submission was received.
What is the product code of K201049?
The FDA product code is JBF – Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening, a Class II (moderate risk) device regulated under 21 CFR 864.7360.